Narrative review / 2011
The USP Dietary Supplements Information Expert Committee assigned a Class A safety rating to Spirulina maxima and S. platensis.
The Dietary Supplements Information Expert Committee (DSI-EC) of the USP evaluated the safety of spirulina to determine its eligibility for quality monographs in the USP-NF. The committee reviewed data from human clinical trials, animal studies, regulatory sources, and analyzed 31 adverse event reports. Based on the review, DSI-EC assigned a Class A safety rating for Spirulina maxima and S. platensis, permitting their admission as quality monographs.
- Study type
- Safety review and adverse event analysis
- Who was studied
- Human clinical trials, animal studies, and 31 adverse event reports
- What was measured
- Safety rating of spirulina for USP-NF monograph admission
THE PAPER
United States pharmacopeia safety evaluation of spirulina.
Marles RJ, Barrett ML, Barnes J, Chavez ML, Gardiner P, Ko R, Mahady GB, Low Dog T, Sarma ND, Giancaspro GI, Sharaf M, Griffiths J. Crit Rev Food Sci Nutr, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.